GlassScriptPhysician profile
Steven Bhutra
NPI 1346696853
$13,098.71
in general payments reported to CMS, 2019-2025
30 companies · $17.93 in 2025
The $17.93 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $315 · 2021: $3,885 · 2022: $5,195 · 2023: $1,673 · 2024: $2,013 · 2025: $17.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,124 · Travel and Lodging: $1,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,123.83 |
| Travel and Lodging | $1,580.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,928.67 | 2020-2025 | Superion Indirect Decompression System, General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $2,374.63 | 2021-2024 | Intellis Adaptivestim, Cd Horizon Spinal System |
| Nevro Corp. | $1,825.51 | 2021-2024 | Senza |
| Spinal Simplicity, LLC | $1,435.09 | 2022-2023 | Ha Minuteman G3-R |
| Abbott Laboratories | $1,132.95 | 2021-2024 | Eterna, Proclaim |
| Stimwave Technologies Incorporated | $907.66 | 2021-2022 | |
| Stryker Corporation | $767.14 | 2021 | |
| Relievant Medsystems, INC. | $476.95 | 2022-2023 | Intracept |
| Medtronic USA, INC. | $218.22 | 2020 | |
| Nalu Medical, INC. | $201.20 | 2021-2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $198.78 | 2021-2024 | Xtampza, Belbuca |
| Foundation Fusion Solutions, LLC | $145.51 | 2021-2022 | |
| Abbvie INC. | $80.90 | 2022-2024 | Botox |
| Curonix LLC | $63.98 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Allergan, INC. | $47.15 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $37.95 | 2024 | Affirm, Si-Lok |
| Painteq LLC | $30.17 | 2023-2024 | Painteq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.20 | 2024 | Relistor |
| Pacira Pharmaceuticals Incorporated | $21.70 | 2023 | Exparel, Zilretta, Iovera |
| Grt US Holding, INC. | $21.53 | 2022 | |
| Amgen INC. | $18.69 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $17.37 | 2022 | |
| Averitas Pharma INC. | $16.79 | 2024 | Qutenza |
| Arbor Pharmaceuticals, INC. | $16.33 | 2022 | |
| Ibsa Pharma INC. | $16.16 | 2022 | |
| Mml US, INC. | $15.61 | 2023 | Reactiv8 |
| Convatec INC. | $15.60 | 2023 | |
| Spr Therapeutics, INC | $15.20 | 2024 | Sprint Pns System |
| Saluda Medical Americas, INC. | $14.15 | 2024 | Evoke |
| Vertos Medical, INC. | $13.92 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bhutra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.